CiTherapeutics
Advanced Cannabis Formulations
Health Tech & Life Sciences
Non Active, May 2019 ceased to operate
Company Overview
Snapshot
Founded in May 2019 by Saul Kaye, CiTherapeutics operated with 1–10 employees. The company ceased operations in May 2019.
Business overview
CiTherapeutics is a Health Tech & Life Sciences company focused on developing advanced cannabis formulations. The company's core product pipeline includes formulations for sleep disorders, with products like Nebican, Breeve, iCAN Sleep, and GasTrap Reactor. CiTherapeutics aims to deliver clinically validated, unique formulations using pharmaceutical-grade delivery systems, serving the medical cannabis and pharmaceutical sectors.
Log in to access full profile ›Company Intelligence Q&A
- What is CiTherapeutics' primary focus?
- CiTherapeutics is dedicated to bringing advanced cannabis formulations to market, with a specific focus on developing products for sleep disorders and other conditions.
- When was CiTherapeutics founded?
- CiTherapeutics was founded in May 2019.
- Who founded CiTherapeutics?
- CiTherapeutics was founded by Saul Kaye.
- What is the operational status of CiTherapeutics?
- CiTherapeutics ceased to operate in May 2019.
- What types of products does CiTherapeutics develop?
- CiTherapeutics develops advanced cannabis formulations, including products like nebican, Breeve, iCAN Sleep, and GasTrap Reactor, with an initial focus on sleep disorders.